Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Several minimally invasive image guided tumor ablation techniques have been added to the treatment spectrum for locally advanced pancreatic cancer (LAPC). Irreversible electroporation (IRE) might have a significant additive value in the management of this difficult-to-treat disease. As opposed to th...
Saved in:
| Published in | Techniques in vascular and interventional radiology Vol. 23; no. 2; p. 100675 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.06.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Several minimally invasive image guided tumor ablation techniques have been added to the treatment spectrum for locally advanced pancreatic cancer (LAPC). Irreversible electroporation (IRE) might have a significant additive value in the management of this difficult-to-treat disease.
As opposed to thermal ablative techniques, IRE induces cell death by the delivery of high-voltage electrical pulses. The electrical energy disrupts the cellular membrane integrity, causes loss of cellular homeostasis and ultimately results in cell death. The extracellular matrix of connective tissue in surrounding delicate structures such as bile ducts, bowel wall, and larger blood vessels is spared. The preservation of these structures makes IRE attractive for the treatment of pancreatic cancers that are unresectable due to their anatomical location (ie, LAPC and local recurrence after surgical resection). In addition to its cytoreductive abilities, evidence is emerging on IRE's capability to induce systemic immunomodulation through active in vivo vaccination against pancreatic cancer cells. These effects in combination with immunotherapy may offer a new treatment paradigm for tumors with low immunogenic potential like pancreatic ductal adenocarcinoma (PDAC).
This review discusses several practical and technical issues of IRE for LAPC: clinical evaluation, indications, patient preparations, procedural steps, imaging characteristics, clinical results, and “tricks of the trade” used to improve the safety and efficacy of the treatment. Future directions such as the combination of IRE with immunotherapy will be shortly addressed. |
|---|---|
| AbstractList | Several minimally invasive image guided tumor ablation techniques have been added to the treatment spectrum for locally advanced pancreatic cancer (LAPC). Irreversible electroporation (IRE) might have a significant additive value in the management of this difficult-to-treat disease.
As opposed to thermal ablative techniques, IRE induces cell death by the delivery of high-voltage electrical pulses. The electrical energy disrupts the cellular membrane integrity, causes loss of cellular homeostasis and ultimately results in cell death. The extracellular matrix of connective tissue in surrounding delicate structures such as bile ducts, bowel wall, and larger blood vessels is spared. The preservation of these structures makes IRE attractive for the treatment of pancreatic cancers that are unresectable due to their anatomical location (ie, LAPC and local recurrence after surgical resection). In addition to its cytoreductive abilities, evidence is emerging on IRE's capability to induce systemic immunomodulation through active in vivo vaccination against pancreatic cancer cells. These effects in combination with immunotherapy may offer a new treatment paradigm for tumors with low immunogenic potential like pancreatic ductal adenocarcinoma (PDAC).
This review discusses several practical and technical issues of IRE for LAPC: clinical evaluation, indications, patient preparations, procedural steps, imaging characteristics, clinical results, and “tricks of the trade” used to improve the safety and efficacy of the treatment. Future directions such as the combination of IRE with immunotherapy will be shortly addressed. |
| ArticleNumber | 100675 |
| Author | de Vries, Jan J.J. Schouten, Evelien A.C. Nieuwenhuizen, Sanne Meijerink, Martijn R. Scheffer, Hester J. Puijk, Robbert S. Geboers, Bart Ruarus, Alette H. Timmer, Florentine E.F. |
| Author_xml | – sequence: 1 givenname: Florentine E.F. surname: Timmer fullname: Timmer, Florentine E.F. – sequence: 2 givenname: Bart surname: Geboers fullname: Geboers, Bart email: b.geboers@amsterdamumc.nl – sequence: 3 givenname: Alette H. surname: Ruarus fullname: Ruarus, Alette H. – sequence: 4 givenname: Evelien A.C. surname: Schouten fullname: Schouten, Evelien A.C. – sequence: 5 givenname: Sanne surname: Nieuwenhuizen fullname: Nieuwenhuizen, Sanne – sequence: 6 givenname: Robbert S. surname: Puijk fullname: Puijk, Robbert S. – sequence: 7 givenname: Jan J.J. surname: de Vries fullname: de Vries, Jan J.J. – sequence: 8 givenname: Martijn R. surname: Meijerink fullname: Meijerink, Martijn R. – sequence: 9 givenname: Hester J. surname: Scheffer fullname: Scheffer, Hester J. |
| BookMark | eNp9kM1qwzAQhEVJoUnaF-jJx16c6ieyZOglmDQNBNpDexaqvAYFx0pXjiFvXxn33NMOuzML8y3IrAsdEPLI6IpRVjwfV_3gccUpHxe0UPKGzJmUKi811bOkqS5zLllxRxYxHilNWuo5qfaIMABG_91Ctm3B9RjOAW3vQ5c1AbNDcLZtr9mmHmznoM4-0kBIBpdV4wbvyW1j2wgPf3NJvl63n9Vbfnjf7avNIXdCqT4Hyphq1kmD5LxmjBbCuqIUNS-ULqmSJdeqboQAJ7WwDZfgalAFrEtIF7EkT9PfM4afC8TenHx00La2g3CJhq-ZZoKXVCQrn6wOQ4wIjTmjP1m8GkbNSMwczUjMjMTMRCyFXqYQpBKDBzTReRg7e0xcTB38f_Ff5oh1cQ |
| CitedBy_id | crossref_primary_10_1016_j_diii_2022_09_009 crossref_primary_10_1148_radiol_230139 crossref_primary_10_1259_bjr_20211360 crossref_primary_10_1080_2162402X_2021_1984677 crossref_primary_10_3390_cancers13153902 crossref_primary_10_3390_life13030835 crossref_primary_10_1016_j_jvir_2023_06_027 crossref_primary_10_3390_ijms241612681 crossref_primary_10_3748_wjg_v29_i2_223 crossref_primary_10_1590_0100_3984_2022_0032 crossref_primary_10_3748_wjg_v27_i23_3413 crossref_primary_10_1007_s11548_024_03216_w crossref_primary_10_3390_s20216227 crossref_primary_10_1002_adma_202310856 crossref_primary_10_1016_j_jimed_2022_10_001 crossref_primary_10_1016_S2468_1253_24_00017_7 crossref_primary_10_3390_cancers14174257 crossref_primary_10_1016_j_rx_2023_04_007 crossref_primary_10_1016_j_rxeng_2023_04_002 crossref_primary_10_1053_j_seminoncol_2021_02_004 crossref_primary_10_1007_s11912_023_01452_y crossref_primary_10_1016_j_hbpd_2021_06_004 crossref_primary_10_1016_j_hpb_2021_12_014 crossref_primary_10_1089_bioe_2022_0031 crossref_primary_10_1016_j_ejso_2021_05_024 crossref_primary_10_1016_j_heliyon_2023_e23551 crossref_primary_10_1590_0100_3984_2022_0032_en crossref_primary_10_1080_02656736_2023_2247187 crossref_primary_10_3390_jcm10081609 crossref_primary_10_1007_s40137_023_00370_z crossref_primary_10_1080_02656736_2021_1972171 |
| Cites_doi | 10.1016/j.hpb.2016.06.015 10.1002/bjs.9536 10.1038/s41467-019-08782-1 10.1016/j.jvir.2016.10.023 10.1245/s10434-019-07261-7 10.1007/s11307-016-0959-4 10.1007/s00270-013-0704-1 10.1016/j.diii.2017.07.007 10.1002/jso.25110 10.1080/02656736.2018.1539253 10.1002/pros.22986 10.1016/j.jvir.2018.07.009 10.1007/s00464-016-5173-6 10.1016/j.pan.2015.08.010 10.1148/radiol.2020192190 10.1016/j.ejso.2016.01.024 10.1159/000375323 10.1097/SLA.0000000000001441 10.3390/cancers10010016 10.1007/s10439-017-1889-2 10.1016/j.amjsurg.2019.03.020 10.2169/internalmedicine.0861-18 10.1111/j.1365-2559.2004.01919.x 10.21873/anticanres.13371 10.1016/j.jvir.2015.10.020 10.1245/s10434-018-07144-3 10.1016/j.jvir.2015.12.025 10.1097/MPA.0000000000000473 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R 10.1200/JCO.2011.34.8904 10.1016/S0140-6736(10)62307-0 10.1186/1475-925X-14-S3-S4 10.1109/TBME.2010.2102021 10.1016/j.ejca.2008.10.026 10.21037/jgo.2018.01.14 10.1177/1536012117709384 10.3748/wjg.v24.i19.2047 10.1111/his.13975 10.1259/0007-1285-26-305-234 10.1148/radiol.2016152835 10.1371/journal.pone.0148457 10.1007/978-3-319-55113-5 10.1016/j.ijsu.2015.06.049 10.1245/s10434-017-5900-9 10.1080/2162402X.2019.1652532 10.1038/nrc3672 10.1053/j.tvir.2013.08.002 10.1148/radiol.2015151166 10.1080/02656736.2018.1473893 10.1016/j.jvir.2010.12.014 10.1148/radiol.13130349 10.1007/s00432-017-2513-4 10.1155/2019/9346017 10.1097/MPA.0000000000000767 10.1007/s00270-018-1971-7 10.18632/oncotarget.21974 10.1007/s00330-016-4581-2 10.1245/s10434-016-5373-2 10.1371/journal.pone.0166987 10.1007/s00270-014-0950-x 10.2967/jnumed.112.110759 10.1053/j.tvir.2015.06.007 10.1007/s12325-010-0085-7 10.1245/s10434-015-5034-x 10.1016/j.jvir.2014.06.026 |
| ContentType | Journal Article |
| Copyright | 2020 The Author(s) |
| Copyright_xml | – notice: 2020 The Author(s) |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 |
| DOI | 10.1016/j.tvir.2020.100675 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1557-9808 |
| EndPage | 100675 |
| ExternalDocumentID | 10_1016_j_tvir_2020_100675 S108925162030024X |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1~. 1~5 4.4 457 4CK 4G. 53G 5VS 6I. 6PF 7-5 71M 8P~ AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAWTL AAXUO ABBQC ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AEVXI AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OI~ OU0 OZT P-8 P-9 PC. Q38 R2- RIG ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K Z5R ~G- AAXKI AAYXX ACRPL ADNMO ADVLN AFCTW AFJKZ AKRWK CITATION 7X8 |
| ID | FETCH-LOGICAL-c377t-e0117f4377e522d11063ac693d267890759287df33ec583af25ecde76e49e2873 |
| IEDL.DBID | AIKHN |
| ISSN | 1089-2516 |
| IngestDate | Tue Dec 03 23:43:36 EST 2024 Fri Dec 06 04:09:28 EST 2024 Fri Feb 23 02:47:28 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | immunomodulation image-guided ablation immunotherapy locally advanced pancreatic cancer abscopal effect irreversible electroporation |
| Language | English |
| License | This is an open access article under the CC BY license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c377t-e0117f4377e522d11063ac693d267890759287df33ec583af25ecde76e49e2873 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S108925162030024X |
| PQID | 2418132903 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_2418132903 crossref_primary_10_1016_j_tvir_2020_100675 elsevier_sciencedirect_doi_10_1016_j_tvir_2020_100675 |
| PublicationCentury | 2000 |
| PublicationDate | June 2020 2020-06-00 20200601 |
| PublicationDateYYYYMMDD | 2020-06-01 |
| PublicationDate_xml | – month: 06 year: 2020 text: June 2020 |
| PublicationDecade | 2020 |
| PublicationTitle | Techniques in vascular and interventional radiology |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Vogel, Rombouts, de Rooij (bib0017) 2017; 24 Chu, Dupuy (bib0012) 2014; 14 Dollinger, Jung, Beyer (bib0038) 2014; 25 Tseng, Molenaar, Besselink (bib0035) 2016; 45 Eisenhauer, Therasse, Bogaerts (bib0041) 2009; 45 Steiger, Schlitter, Weichert (bib0028) 2017; 16 Scheffer, Melenhorst, Echenique (bib0034) 2015; 18 Miklovic, Latouche, DeWitt (bib0055) 2017; 45 Geboers, Scheffer, Graybill (bib0009) 2020; 295 Stillström, Nilsson, Jesse (bib0071) 2017; 31 Vroomen, Scheffer, Melenhorst (bib0039) 2017; 27 Khushman, Dempsey, Maldonado (bib0053) 2015; 15 Huang, Yang, Pua (bib0049) 2018; 118 de Geus, Boogerd, Swijnenburg (bib0026) 2016; 18 Knavel, Brace (bib0032) 2013; 16 Netherlands Comprehensive Cancer Organisation (IKNL). 2019. Available online Sipos, Hahn, Carceller (bib0025) 2004; 45 Lin, Alnaggar, Liang (bib0064) 2017; 8 He, Wang, Sun (bib0060) 2019; 2019 Scheffer, Stam, Geboers (bib0004) 2019; 8 Nagtegaal, Odze, Klimstra (bib0040) 2020; 76 Zhang, Sanagapalli, Stoita (bib0022) 2018; 24 Davalos, Bhonsle, Neal (bib0046) 2015; 75 Field, Rostas, Martin (bib0051) 2019; 218 Ruarus, Vroomen, Puijk (bib0045) 2018; 41 Lambert, Horejs, Krska (bib0069) 2016; 63 Bulvik, Rozenblum, Gourevich (bib0015) 2016; 280 Hackel, Kimura, Miao (bib0027) 2013; 54 Scheffer, Vogel, van den Bos (bib0021) 2016; 11 Shao, O'Flanagan, Lam (bib0014) 2019; 36 Saito, Hirano, Isayama (bib0036) 2017; 46 Siddiqui, Latouche, DeWitt (bib0057) 2016; 18 . Mansson, Bergenfeldt, Brahmstaedt (bib0008) 2014; 34 Ruarus, Vroomen, Geboers (bib0016) 2019 Mansson, Brahmstaedt, Nygren (bib0052) 2019; 39 Moris, Machairas, Tsilimigras (bib0044) 2019; 26 Meijerink M, Scheffer H, Narayanan G. Irreversible electroporation in clinical practice. 2018. Leen, Picard, Stebbing (bib0048) 2018; 9 Niederhuber, Brennan, Menck (bib0002) 1995; 76 Dunki-Jacobs, Philips, Martin (bib0018) 2014; 101 O'Brien, Bonakdar, Bhonsle (bib0047) 2018; 35 Spiliotis, Kopanakis, Terras (bib0072) 2018; 23 Loehrer, Feng, Cardenes (bib0003) 2011; 29 Neal, 2nd, Kavnoudias (bib0020) 2013; 36 Mansson, Brahmstaedt, Nilsson (bib0066) 2016; 42 Paiella, Butturini, Frigerio (bib0067) 2015; 32 Appelbaum, Ben-David, Faroja (bib0033) 2014; 270 Niessen, Beyer, Pregler (bib0006) 2016; 27 Arena, Sano, Rylander (bib0056) 2011; 58 Ruarus, Vroomen, Puijk (bib0043) 2018; 10 Vogel, van Veldhuisen, Agnass (bib0011) 2016; 11 Best, Rawji, Pereira (bib0024) 2017; 4 Kluger, Epelboym, Schrope (bib0068) 2016; 23 van den Bos, Scheffer, Vogel (bib0054) 2016; 27 Vincent, Herman, Schulick (bib0059) 2011; 378 Marcan, Pavliha, Kos (bib0042) 2015; 14 Belfiore, Ronza, Romano (bib0070) 2015; 21 Zhao, Wen, Tian (bib0063) 2019; 10 Sugimoto, Moriyasu, Tsuchiya (bib0073) 2018; 57 White, Zhang, Chen (bib0013) 2018; 29 Nguyen, Nguyen, Nguyen (bib0023) 2011; 12 Kuhn, Gelrud, Munck (bib0037) 2010; 27 Lin, Liang, Wang (bib0065) 2017; 143 Rombouts, Walma, Vogel (bib0058) 2016; 23 Martin, 2nd, Chalikonda (bib0007) 2015; 262 Mole (bib0062) 1953; 26 Vroomen, Petre, Cornelis (bib0010) 2017; 98 Scheffer, Melenhorst, Vogel (bib0030) 2015; 38 Scheffer, Vroomen, de Jong (bib0005) 2017; 282 Thomson, Cheung, Ellis (bib0029) 2011; 22 Narayanan, Hosein, Beulaygue (bib0050) 2017; 28 Pandit, Hong, Li (bib0061) 2019; 26 Mansson, Nilsson, Karlson (bib0019) 2014; 3 Scheffer (10.1016/j.tvir.2020.100675_bib0030) 2015; 38 Tseng (10.1016/j.tvir.2020.100675_bib0035) 2016; 45 White (10.1016/j.tvir.2020.100675_bib0013) 2018; 29 Miklovic (10.1016/j.tvir.2020.100675_bib0055) 2017; 45 Kluger (10.1016/j.tvir.2020.100675_bib0068) 2016; 23 van den Bos (10.1016/j.tvir.2020.100675_bib0054) 2016; 27 Arena (10.1016/j.tvir.2020.100675_bib0056) 2011; 58 Eisenhauer (10.1016/j.tvir.2020.100675_bib0041) 2009; 45 Paiella (10.1016/j.tvir.2020.100675_bib0067) 2015; 32 Niessen (10.1016/j.tvir.2020.100675_bib0006) 2016; 27 Steiger (10.1016/j.tvir.2020.100675_bib0028) 2017; 16 10.1016/j.tvir.2020.100675_bib0031 Vogel (10.1016/j.tvir.2020.100675_bib0011) 2016; 11 Khushman (10.1016/j.tvir.2020.100675_bib0053) 2015; 15 Huang (10.1016/j.tvir.2020.100675_bib0049) 2018; 118 Lin (10.1016/j.tvir.2020.100675_bib0065) 2017; 143 Chu (10.1016/j.tvir.2020.100675_bib0012) 2014; 14 Dollinger (10.1016/j.tvir.2020.100675_bib0038) 2014; 25 Marcan (10.1016/j.tvir.2020.100675_bib0042) 2015; 14 de Geus (10.1016/j.tvir.2020.100675_bib0026) 2016; 18 Geboers (10.1016/j.tvir.2020.100675_bib0009) 2020; 295 Appelbaum (10.1016/j.tvir.2020.100675_bib0033) 2014; 270 Mansson (10.1016/j.tvir.2020.100675_bib0066) 2016; 42 Mansson (10.1016/j.tvir.2020.100675_bib0008) 2014; 34 Field (10.1016/j.tvir.2020.100675_bib0051) 2019; 218 Lin (10.1016/j.tvir.2020.100675_bib0064) 2017; 8 Sugimoto (10.1016/j.tvir.2020.100675_bib0073) 2018; 57 Davalos (10.1016/j.tvir.2020.100675_bib0046) 2015; 75 Nguyen (10.1016/j.tvir.2020.100675_bib0023) 2011; 12 Niederhuber (10.1016/j.tvir.2020.100675_bib0002) 1995; 76 Dunki-Jacobs (10.1016/j.tvir.2020.100675_bib0018) 2014; 101 Best (10.1016/j.tvir.2020.100675_bib0024) 2017; 4 Vincent (10.1016/j.tvir.2020.100675_bib0059) 2011; 378 Mole (10.1016/j.tvir.2020.100675_bib0062) 1953; 26 Moris (10.1016/j.tvir.2020.100675_bib0044) 2019; 26 Pandit (10.1016/j.tvir.2020.100675_bib0061) 2019; 26 Scheffer (10.1016/j.tvir.2020.100675_bib0034) 2015; 18 Vroomen (10.1016/j.tvir.2020.100675_bib0039) 2017; 27 Leen (10.1016/j.tvir.2020.100675_bib0048) 2018; 9 Nagtegaal (10.1016/j.tvir.2020.100675_bib0040) 2020; 76 Rombouts (10.1016/j.tvir.2020.100675_bib0058) 2016; 23 Scheffer (10.1016/j.tvir.2020.100675_bib0021) 2016; 11 Hackel (10.1016/j.tvir.2020.100675_bib0027) 2013; 54 Lambert (10.1016/j.tvir.2020.100675_bib0069) 2016; 63 Shao (10.1016/j.tvir.2020.100675_bib0014) 2019; 36 Ruarus (10.1016/j.tvir.2020.100675_bib0045) 2018; 41 Sipos (10.1016/j.tvir.2020.100675_bib0025) 2004; 45 Zhang (10.1016/j.tvir.2020.100675_bib0022) 2018; 24 Zhao (10.1016/j.tvir.2020.100675_bib0063) 2019; 10 He (10.1016/j.tvir.2020.100675_bib0060) 2019; 2019 Mansson (10.1016/j.tvir.2020.100675_bib0019) 2014; 3 Scheffer (10.1016/j.tvir.2020.100675_bib0005) 2017; 282 Siddiqui (10.1016/j.tvir.2020.100675_bib0057) 2016; 18 Vroomen (10.1016/j.tvir.2020.100675_bib0010) 2017; 98 Belfiore (10.1016/j.tvir.2020.100675_bib0070) 2015; 21 O'Brien (10.1016/j.tvir.2020.100675_bib0047) 2018; 35 Neal (10.1016/j.tvir.2020.100675_bib0020) 2013; 36 Kuhn (10.1016/j.tvir.2020.100675_bib0037) 2010; 27 Ruarus (10.1016/j.tvir.2020.100675_bib0043) 2018; 10 Vogel (10.1016/j.tvir.2020.100675_bib0017) 2017; 24 Mansson (10.1016/j.tvir.2020.100675_bib0052) 2019; 39 Loehrer (10.1016/j.tvir.2020.100675_bib0003) 2011; 29 Martin (10.1016/j.tvir.2020.100675_bib0007) 2015; 262 10.1016/j.tvir.2020.100675_bib0001 Bulvik (10.1016/j.tvir.2020.100675_bib0015) 2016; 280 Scheffer (10.1016/j.tvir.2020.100675_bib0004) 2019; 8 Saito (10.1016/j.tvir.2020.100675_bib0036) 2017; 46 Ruarus (10.1016/j.tvir.2020.100675_bib0016) 2019 Spiliotis (10.1016/j.tvir.2020.100675_bib0072) 2018; 23 Stillström (10.1016/j.tvir.2020.100675_bib0071) 2017; 31 Narayanan (10.1016/j.tvir.2020.100675_bib0050) 2017; 28 Thomson (10.1016/j.tvir.2020.100675_bib0029) 2011; 22 Knavel (10.1016/j.tvir.2020.100675_bib0032) 2013; 16 |
| References_xml | – volume: 18 start-page: 726 year: 2016 end-page: 734 ident: bib0057 article-title: Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo publication-title: HPB (Oxford) contributor: fullname: DeWitt – volume: 14 start-page: 199 year: 2014 ident: bib0012 article-title: Thermal ablation of tumours: Biological mechanisms and advances in therapy publication-title: Nat Rev Cancer contributor: fullname: Dupuy – volume: 58 start-page: 1474 year: 2011 end-page: 1482 ident: bib0056 article-title: Theoretical considerations of tissue electroporation with high-frequency bipolar pulses publication-title: IEEE Trans Bio-med Eng contributor: fullname: Rylander – volume: 14 start-page: S4 year: 2015 ident: bib0042 article-title: Web-based tool for visualization of electric field distribution in deep-seated body structures and planning of electroporation-based treatments publication-title: Biomed Eng Online contributor: fullname: Kos – volume: 41 start-page: 1257 year: 2018 end-page: 1266 ident: bib0045 article-title: Conductivity rise during irreversible electroporation: True permeabilization or heat? publication-title: Cardiovasc Intervent Radiol contributor: fullname: Puijk – volume: 75 start-page: 1114 year: 2015 end-page: 1118 ident: bib0046 article-title: Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy publication-title: Prostate contributor: fullname: Neal – volume: 295 start-page: 254 year: 2020 end-page: 272 ident: bib0009 article-title: High-voltage electrical pulses in oncology: Irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy publication-title: Radiology contributor: fullname: Graybill – volume: 16 start-page: 192 year: 2013 end-page: 200 ident: bib0032 article-title: Tumor ablation: common modalities and general practices publication-title: Tech Vasc Interv Radiol contributor: fullname: Brace – volume: 23 start-page: 1203 year: 2018 end-page: 1204 ident: bib0072 article-title: Irreversible electroporation for Stage III locally advanced pancreatic cancer: Single-center experience publication-title: J BUON contributor: fullname: Terras – volume: 262 start-page: 486 year: 2015 end-page: 494 ident: bib0007 article-title: Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: Safety and efficacy publication-title: Ann Surg contributor: fullname: Chalikonda – volume: 98 start-page: 609 year: 2017 end-page: 617 ident: bib0010 article-title: Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? publication-title: Diagnost Intervent Imaging contributor: fullname: Cornelis – volume: 280 start-page: 413 year: 2016 end-page: 424 ident: bib0015 article-title: Irreversible electroporation versus radiofrequency ablation: A comparison of local and systemic effects in a small-animal model publication-title: Radiology contributor: fullname: Gourevich – volume: 26 start-page: 234 year: 1953 end-page: 241 ident: bib0062 article-title: Whole body irradiation; radiobiology or medicine? publication-title: Br J Radiol contributor: fullname: Mole – volume: 2019 year: 2019 ident: bib0060 article-title: Immunomodulatory effect after irreversible electroporation in patients with locally advanced pancreatic cancer publication-title: J Oncol contributor: fullname: Sun – volume: 76 start-page: 1671 year: 1995 end-page: 1677 ident: bib0002 article-title: The National Cancer Data Base report on pancreatic cancer publication-title: Cancer contributor: fullname: Menck – year: 2019 ident: bib0016 article-title: Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): A multicenter, prospective, single-arm, phase II study publication-title: Radiology contributor: fullname: Geboers – volume: 282 start-page: 585 year: 2017 end-page: 597 ident: bib0005 article-title: Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: Results of the phase I/II PANFIRE study publication-title: Radiology contributor: fullname: de Jong – volume: 27 start-page: 433 year: 2016 end-page: 443 ident: bib0054 article-title: Thermal energy during irreversible electroporation and the influence of different ablation parameters publication-title: J Vasc Interv Radiol contributor: fullname: Vogel – volume: 39 start-page: 2509 year: 2019 end-page: 2512 ident: bib0052 article-title: Percutaneous irreversible electroporation as first-line treatment of locally advanced pancreatic cancer publication-title: Anticancer Res contributor: fullname: Nygren – volume: 22 start-page: 611 year: 2011 end-page: 621 ident: bib0029 article-title: Investigation of the safety of irreversible electroporation in humans publication-title: J Vasc Intervent Radiol contributor: fullname: Ellis – volume: 25 start-page: 1589 year: 2014 end-page: 1594 ident: bib0038 article-title: Irreversible electroporation ablation of malignant hepatic tumors: Subacute and follow-up CT appearance of ablation zones publication-title: J Vasc Interv Radiol contributor: fullname: Beyer – volume: 16 year: 2017 ident: bib0028 article-title: Perspective of αvβ6-integrin imaging for clinical management of pancreatic carcinoma and its precursor lesions publication-title: Mol Imaging contributor: fullname: Weichert – volume: 218 start-page: 571 year: 2019 end-page: 578 ident: bib0051 article-title: Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC) publication-title: Am J Surg contributor: fullname: Martin – volume: 36 start-page: 130 year: 2019 end-page: 138 ident: bib0014 article-title: Engineering T cell response to cancer antigens by choice of focal therapeutic conditions publication-title: Int J Hyperthermia contributor: fullname: Lam – volume: 12 start-page: 557 year: 2011 end-page: 566 ident: bib0023 article-title: (1)(8)F-FDG PET/CT imaging of the pancreas: Spectrum of diseases publication-title: Jop contributor: fullname: Nguyen – volume: 29 start-page: 1764 year: 2018 end-page: 1769 ident: bib0013 article-title: Early immunologic response of irreversible electroporation versus cryoablation in a rodent model of pancreatic cancer publication-title: J Vasc Intervent Radiol contributor: fullname: Chen – volume: 23 start-page: 4352 year: 2016 end-page: 4360 ident: bib0058 article-title: Systematic review of resection rates and clinical outcomes after FOLFIRINOX-based treatment in patients with locally advanced pancreatic cancer publication-title: Ann Surg Oncol contributor: fullname: Vogel – volume: 76 start-page: 182 year: 2020 end-page: 188 ident: bib0040 article-title: The 2019 WHO classification of tumours of the digestive system publication-title: Histopathology contributor: fullname: Klimstra – volume: 57 start-page: 3225 year: 2018 end-page: 3231 ident: bib0073 article-title: Irreversible electroporation for nonthermal tumor ablation in patients with locally advanced pancreatic cancer: Initial clinical experience in Japan publication-title: Int Med (Tokyo, Japan) contributor: fullname: Tsuchiya – volume: 21 start-page: S34 year: 2015 end-page: SS9 ident: bib0070 article-title: Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience publication-title: Int J Surg contributor: fullname: Romano – volume: 34 start-page: 289 year: 2014 end-page: 293 ident: bib0008 article-title: Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer publication-title: Anticancer Res contributor: fullname: Brahmstaedt – volume: 8 year: 2019 ident: bib0004 article-title: Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation publication-title: Oncoimmunology contributor: fullname: Geboers – volume: 270 start-page: 416 year: 2014 end-page: 424 ident: bib0033 article-title: Irreversible electroporation ablation: Creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays publication-title: Radiology contributor: fullname: Faroja – volume: 10 start-page: 16 year: 2018 ident: bib0043 article-title: Locally advanced pancreatic cancer: A review of local ablative therapies publication-title: Cancers (Basel) contributor: fullname: Puijk – volume: 42 start-page: 1401 year: 2016 end-page: 1406 ident: bib0066 article-title: Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy publication-title: Eur J Surg Oncol contributor: fullname: Nilsson – volume: 63 start-page: 269 year: 2016 end-page: 273 ident: bib0069 article-title: Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: General hospital cancer center experience publication-title: Neoplasma contributor: fullname: Krska – volume: 31 start-page: 1982 year: 2017 end-page: 1985 ident: bib0071 article-title: A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas publication-title: Surg Endosc contributor: fullname: Jesse – volume: 32 start-page: 90 year: 2015 end-page: 97 ident: bib0067 article-title: Safety and feasibility of irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer: Results of a prospective study publication-title: Digest Surg contributor: fullname: Frigerio – volume: 27 start-page: 895 year: 2010 end-page: 916 ident: bib0037 article-title: CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency publication-title: Adv Ther contributor: fullname: Munck – volume: 8 start-page: 101795 year: 2017 end-page: 101807 ident: bib0064 article-title: An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer publication-title: Oncotarget contributor: fullname: Liang – volume: 101 start-page: 1113 year: 2014 end-page: 1121 ident: bib0018 article-title: Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model publication-title: Br J Surg contributor: fullname: Martin – volume: 3 year: 2014 ident: bib0019 article-title: Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: A warning of a procedure that never should be performed publication-title: Acta Radiol Short Rep contributor: fullname: Karlson – volume: 45 start-page: 226 year: 2004 end-page: 236 ident: bib0025 article-title: Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro publication-title: Histopathology contributor: fullname: Carceller – volume: 45 start-page: 2524 year: 2017 end-page: 2534 ident: bib0055 article-title: A comprehensive characterization of parameters affecting high-frequency irreversible electroporation lesions publication-title: Ann Biomed Eng contributor: fullname: DeWitt – volume: 118 start-page: 31 year: 2018 end-page: 36 ident: bib0049 article-title: The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma publication-title: J Surg Oncol contributor: fullname: Pua – volume: 23 start-page: 1736 year: 2016 end-page: 1743 ident: bib0068 article-title: Single-institution experience with irreversible electroporation for T4 pancreatic cancer: First 50 patients publication-title: Ann Surg Oncol contributor: fullname: Schrope – volume: 45 start-page: 325 year: 2016 end-page: 330 ident: bib0035 article-title: Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: A systematic review publication-title: Pancreas contributor: fullname: Besselink – volume: 46 start-page: 341 year: 2017 end-page: 346 ident: bib0036 article-title: The role of pancreatic enzyme replacement therapy in unresectable pancreatic cancer: A prospective cohort study publication-title: Pancreas contributor: fullname: Isayama – volume: 143 start-page: 2607 year: 2017 end-page: 2618 ident: bib0065 article-title: Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: A promising treatment publication-title: J Cancer Res Clin Oncol contributor: fullname: Wang – volume: 4 year: 2017 ident: bib0024 article-title: Imaging modalities for characterising focal pancreatic lesions publication-title: Cochrane Database Syst Rev contributor: fullname: Pereira – volume: 11 year: 2016 ident: bib0011 article-title: Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: A systematic review of experimental studies publication-title: PloS One contributor: fullname: Agnass – volume: 26 start-page: 1657 year: 2019 end-page: 1668 ident: bib0044 article-title: Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer publication-title: Ann Surg Oncol contributor: fullname: Tsilimigras – volume: 36 start-page: 1638 year: 2013 end-page: 1645 ident: bib0020 article-title: The effects of metallic implants on electroporation therapies: Feasibility of irreversible electroporation for brachytherapy salvage publication-title: Cardiovasc Intervent Radiol contributor: fullname: Kavnoudias – volume: 38 start-page: 760 year: 2015 end-page: 765 ident: bib0030 article-title: Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: A case report publication-title: Cardiovasc Intervent Radiol contributor: fullname: Vogel – volume: 24 start-page: 2047 year: 2018 end-page: 2060 ident: bib0022 article-title: Challenges in diagnosis of pancreatic cancer publication-title: World J Gastroenterol contributor: fullname: Stoita – volume: 18 start-page: 159 year: 2015 end-page: 169 ident: bib0034 article-title: Irreversible electroporation for colorectal liver metastases publication-title: Tech Vasc Interv Radiol contributor: fullname: Echenique – volume: 27 start-page: 2521 year: 2017 end-page: 2531 ident: bib0039 article-title: MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation publication-title: Eur Radiol contributor: fullname: Melenhorst – volume: 28 start-page: 342 year: 2017 end-page: 348 ident: bib0050 article-title: Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma publication-title: J Vasc Interv Radiol. contributor: fullname: Beulaygue – volume: 9 start-page: 275 year: 2018 end-page: 281 ident: bib0048 article-title: Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma publication-title: J Gastrointest Oncol contributor: fullname: Stebbing – volume: 15 start-page: 667 year: 2015 end-page: 673 ident: bib0053 article-title: Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma publication-title: Pancreatology contributor: fullname: Maldonado – volume: 54 start-page: 1101 year: 2013 end-page: 1105 ident: bib0027 article-title: 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin alphavbeta6 publication-title: J Nucl Med contributor: fullname: Miao – volume: 27 start-page: 480 year: 2016 end-page: 486 ident: bib0006 article-title: Percutaneous ablation of hepatic tumors using irreversible electroporation: A prospective safety and midterm efficacy study in 34 patients publication-title: J Vasc Interv Radiol contributor: fullname: Pregler – volume: 10 start-page: 899 year: 2019 ident: bib0063 article-title: Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer publication-title: Nat Commun contributor: fullname: Tian – volume: 26 start-page: 800 year: 2019 end-page: 806 ident: bib0061 article-title: Evaluating the regulatory immunomodulation effect of irreversible electroporation (IRE) in pancreatic adenocarcinoma publication-title: Ann Surg Oncol contributor: fullname: Li – volume: 24 start-page: 2734 year: 2017 end-page: 2743 ident: bib0017 article-title: Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): A prospective cohort study publication-title: Ann Surg Oncol contributor: fullname: de Rooij – volume: 35 start-page: 44 year: 2018 end-page: 55 ident: bib0047 article-title: Effects of internal electrode cooling on irreversible electroporation using a perfused organ model publication-title: Int J Hyperthermia contributor: fullname: Bhonsle – volume: 29 start-page: 4105 year: 2011 end-page: 4112 ident: bib0003 article-title: Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial publication-title: J Clin Oncol contributor: fullname: Cardenes – volume: 378 start-page: 607 year: 2011 end-page: 620 ident: bib0059 article-title: Pancreatic cancer publication-title: Lancet contributor: fullname: Schulick – volume: 18 start-page: 807 year: 2016 end-page: 819 ident: bib0026 article-title: Selecting tumor-specific molecular targets in pancreatic adenocarcinoma: Paving the way for image-guided pancreatic surgery publication-title: Mol Imaging Biol contributor: fullname: Swijnenburg – volume: 11 year: 2016 ident: bib0021 article-title: The influence of a metal stent on the distribution of thermal energy during irreversible electroporation publication-title: PLoS One contributor: fullname: van den Bos – volume: 45 start-page: 228 year: 2009 end-page: 247 ident: bib0041 article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) publication-title: Eur J Cancer contributor: fullname: Bogaerts – volume: 18 start-page: 726 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0057 article-title: Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo publication-title: HPB (Oxford) doi: 10.1016/j.hpb.2016.06.015 contributor: fullname: Siddiqui – volume: 101 start-page: 1113 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0018 article-title: Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model publication-title: Br J Surg doi: 10.1002/bjs.9536 contributor: fullname: Dunki-Jacobs – volume: 10 start-page: 899 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0063 article-title: Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer publication-title: Nat Commun doi: 10.1038/s41467-019-08782-1 contributor: fullname: Zhao – volume: 28 start-page: 342 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0050 article-title: Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma publication-title: J Vasc Interv Radiol. doi: 10.1016/j.jvir.2016.10.023 contributor: fullname: Narayanan – volume: 26 start-page: 1657 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0044 article-title: Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-019-07261-7 contributor: fullname: Moris – volume: 18 start-page: 807 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0026 article-title: Selecting tumor-specific molecular targets in pancreatic adenocarcinoma: Paving the way for image-guided pancreatic surgery publication-title: Mol Imaging Biol doi: 10.1007/s11307-016-0959-4 contributor: fullname: de Geus – volume: 36 start-page: 1638 year: 2013 ident: 10.1016/j.tvir.2020.100675_bib0020 article-title: The effects of metallic implants on electroporation therapies: Feasibility of irreversible electroporation for brachytherapy salvage publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-013-0704-1 contributor: fullname: Neal – volume: 4 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0024 article-title: Imaging modalities for characterising focal pancreatic lesions publication-title: Cochrane Database Syst Rev contributor: fullname: Best – volume: 98 start-page: 609 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0010 article-title: Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? publication-title: Diagnost Intervent Imaging doi: 10.1016/j.diii.2017.07.007 contributor: fullname: Vroomen – volume: 118 start-page: 31 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0049 article-title: The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma publication-title: J Surg Oncol doi: 10.1002/jso.25110 contributor: fullname: Huang – volume: 36 start-page: 130 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0014 article-title: Engineering T cell response to cancer antigens by choice of focal therapeutic conditions publication-title: Int J Hyperthermia doi: 10.1080/02656736.2018.1539253 contributor: fullname: Shao – volume: 75 start-page: 1114 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0046 article-title: Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy publication-title: Prostate doi: 10.1002/pros.22986 contributor: fullname: Davalos – volume: 29 start-page: 1764 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0013 article-title: Early immunologic response of irreversible electroporation versus cryoablation in a rodent model of pancreatic cancer publication-title: J Vasc Intervent Radiol doi: 10.1016/j.jvir.2018.07.009 contributor: fullname: White – volume: 63 start-page: 269 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0069 article-title: Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: General hospital cancer center experience publication-title: Neoplasma contributor: fullname: Lambert – volume: 31 start-page: 1982 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0071 article-title: A new technique for minimally invasive irreversible electroporation of tumors in the head and body of the pancreas publication-title: Surg Endosc doi: 10.1007/s00464-016-5173-6 contributor: fullname: Stillström – volume: 15 start-page: 667 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0053 article-title: Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma publication-title: Pancreatology doi: 10.1016/j.pan.2015.08.010 contributor: fullname: Khushman – volume: 295 start-page: 254 year: 2020 ident: 10.1016/j.tvir.2020.100675_bib0009 article-title: High-voltage electrical pulses in oncology: Irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy publication-title: Radiology doi: 10.1148/radiol.2020192190 contributor: fullname: Geboers – volume: 42 start-page: 1401 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0066 article-title: Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2016.01.024 contributor: fullname: Mansson – volume: 32 start-page: 90 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0067 article-title: Safety and feasibility of irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer: Results of a prospective study publication-title: Digest Surg doi: 10.1159/000375323 contributor: fullname: Paiella – volume: 262 start-page: 486 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0007 article-title: Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: Safety and efficacy publication-title: Ann Surg doi: 10.1097/SLA.0000000000001441 contributor: fullname: Martin – volume: 10 start-page: 16 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0043 article-title: Locally advanced pancreatic cancer: A review of local ablative therapies publication-title: Cancers (Basel) doi: 10.3390/cancers10010016 contributor: fullname: Ruarus – volume: 45 start-page: 2524 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0055 article-title: A comprehensive characterization of parameters affecting high-frequency irreversible electroporation lesions publication-title: Ann Biomed Eng doi: 10.1007/s10439-017-1889-2 contributor: fullname: Miklovic – volume: 218 start-page: 571 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0051 article-title: Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC) publication-title: Am J Surg doi: 10.1016/j.amjsurg.2019.03.020 contributor: fullname: Field – volume: 57 start-page: 3225 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0073 article-title: Irreversible electroporation for nonthermal tumor ablation in patients with locally advanced pancreatic cancer: Initial clinical experience in Japan publication-title: Int Med (Tokyo, Japan) doi: 10.2169/internalmedicine.0861-18 contributor: fullname: Sugimoto – volume: 45 start-page: 226 year: 2004 ident: 10.1016/j.tvir.2020.100675_bib0025 article-title: Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro publication-title: Histopathology doi: 10.1111/j.1365-2559.2004.01919.x contributor: fullname: Sipos – volume: 39 start-page: 2509 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0052 article-title: Percutaneous irreversible electroporation as first-line treatment of locally advanced pancreatic cancer publication-title: Anticancer Res doi: 10.21873/anticanres.13371 contributor: fullname: Mansson – volume: 27 start-page: 433 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0054 article-title: Thermal energy during irreversible electroporation and the influence of different ablation parameters publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2015.10.020 contributor: fullname: van den Bos – volume: 26 start-page: 800 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0061 article-title: Evaluating the regulatory immunomodulation effect of irreversible electroporation (IRE) in pancreatic adenocarcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-07144-3 contributor: fullname: Pandit – volume: 27 start-page: 480 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0006 article-title: Percutaneous ablation of hepatic tumors using irreversible electroporation: A prospective safety and midterm efficacy study in 34 patients publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2015.12.025 contributor: fullname: Niessen – volume: 45 start-page: 325 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0035 article-title: Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: A systematic review publication-title: Pancreas doi: 10.1097/MPA.0000000000000473 contributor: fullname: Tseng – volume: 76 start-page: 1671 year: 1995 ident: 10.1016/j.tvir.2020.100675_bib0002 article-title: The National Cancer Data Base report on pancreatic cancer publication-title: Cancer doi: 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R contributor: fullname: Niederhuber – volume: 29 start-page: 4105 year: 2011 ident: 10.1016/j.tvir.2020.100675_bib0003 article-title: Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial publication-title: J Clin Oncol doi: 10.1200/JCO.2011.34.8904 contributor: fullname: Loehrer – volume: 3 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0019 article-title: Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: A warning of a procedure that never should be performed publication-title: Acta Radiol Short Rep contributor: fullname: Mansson – volume: 378 start-page: 607 year: 2011 ident: 10.1016/j.tvir.2020.100675_bib0059 article-title: Pancreatic cancer publication-title: Lancet doi: 10.1016/S0140-6736(10)62307-0 contributor: fullname: Vincent – year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0016 article-title: Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): A multicenter, prospective, single-arm, phase II study publication-title: Radiology contributor: fullname: Ruarus – volume: 14 start-page: S4 issue: Suppl 3 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0042 article-title: Web-based tool for visualization of electric field distribution in deep-seated body structures and planning of electroporation-based treatments publication-title: Biomed Eng Online doi: 10.1186/1475-925X-14-S3-S4 contributor: fullname: Marcan – volume: 12 start-page: 557 year: 2011 ident: 10.1016/j.tvir.2020.100675_bib0023 article-title: (1)(8)F-FDG PET/CT imaging of the pancreas: Spectrum of diseases publication-title: Jop contributor: fullname: Nguyen – volume: 58 start-page: 1474 year: 2011 ident: 10.1016/j.tvir.2020.100675_bib0056 article-title: Theoretical considerations of tissue electroporation with high-frequency bipolar pulses publication-title: IEEE Trans Bio-med Eng doi: 10.1109/TBME.2010.2102021 contributor: fullname: Arena – volume: 23 start-page: 1203 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0072 article-title: Irreversible electroporation for Stage III locally advanced pancreatic cancer: Single-center experience publication-title: J BUON contributor: fullname: Spiliotis – volume: 45 start-page: 228 year: 2009 ident: 10.1016/j.tvir.2020.100675_bib0041 article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) publication-title: Eur J Cancer doi: 10.1016/j.ejca.2008.10.026 contributor: fullname: Eisenhauer – volume: 9 start-page: 275 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0048 article-title: Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2018.01.14 contributor: fullname: Leen – volume: 34 start-page: 289 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0008 article-title: Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer publication-title: Anticancer Res contributor: fullname: Mansson – volume: 16 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0028 article-title: Perspective of αvβ6-integrin imaging for clinical management of pancreatic carcinoma and its precursor lesions publication-title: Mol Imaging doi: 10.1177/1536012117709384 contributor: fullname: Steiger – volume: 24 start-page: 2047 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0022 article-title: Challenges in diagnosis of pancreatic cancer publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i19.2047 contributor: fullname: Zhang – volume: 76 start-page: 182 issue: 2 year: 2020 ident: 10.1016/j.tvir.2020.100675_bib0040 article-title: The 2019 WHO classification of tumours of the digestive system publication-title: Histopathology doi: 10.1111/his.13975 contributor: fullname: Nagtegaal – volume: 26 start-page: 234 year: 1953 ident: 10.1016/j.tvir.2020.100675_bib0062 article-title: Whole body irradiation; radiobiology or medicine? publication-title: Br J Radiol doi: 10.1259/0007-1285-26-305-234 contributor: fullname: Mole – volume: 282 start-page: 585 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0005 article-title: Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: Results of the phase I/II PANFIRE study publication-title: Radiology doi: 10.1148/radiol.2016152835 contributor: fullname: Scheffer – volume: 11 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0021 article-title: The influence of a metal stent on the distribution of thermal energy during irreversible electroporation publication-title: PLoS One doi: 10.1371/journal.pone.0148457 contributor: fullname: Scheffer – ident: 10.1016/j.tvir.2020.100675_bib0031 doi: 10.1007/978-3-319-55113-5 – ident: 10.1016/j.tvir.2020.100675_bib0001 – volume: 21 start-page: S34 issue: Suppl 1 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0070 article-title: Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience publication-title: Int J Surg doi: 10.1016/j.ijsu.2015.06.049 contributor: fullname: Belfiore – volume: 24 start-page: 2734 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0017 article-title: Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): A prospective cohort study publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5900-9 contributor: fullname: Vogel – volume: 8 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0004 article-title: Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation publication-title: Oncoimmunology doi: 10.1080/2162402X.2019.1652532 contributor: fullname: Scheffer – volume: 14 start-page: 199 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0012 article-title: Thermal ablation of tumours: Biological mechanisms and advances in therapy publication-title: Nat Rev Cancer doi: 10.1038/nrc3672 contributor: fullname: Chu – volume: 16 start-page: 192 year: 2013 ident: 10.1016/j.tvir.2020.100675_bib0032 article-title: Tumor ablation: common modalities and general practices publication-title: Tech Vasc Interv Radiol doi: 10.1053/j.tvir.2013.08.002 contributor: fullname: Knavel – volume: 280 start-page: 413 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0015 article-title: Irreversible electroporation versus radiofrequency ablation: A comparison of local and systemic effects in a small-animal model publication-title: Radiology doi: 10.1148/radiol.2015151166 contributor: fullname: Bulvik – volume: 35 start-page: 44 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0047 article-title: Effects of internal electrode cooling on irreversible electroporation using a perfused organ model publication-title: Int J Hyperthermia doi: 10.1080/02656736.2018.1473893 contributor: fullname: O'Brien – volume: 22 start-page: 611 year: 2011 ident: 10.1016/j.tvir.2020.100675_bib0029 article-title: Investigation of the safety of irreversible electroporation in humans publication-title: J Vasc Intervent Radiol doi: 10.1016/j.jvir.2010.12.014 contributor: fullname: Thomson – volume: 270 start-page: 416 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0033 article-title: Irreversible electroporation ablation: Creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays publication-title: Radiology doi: 10.1148/radiol.13130349 contributor: fullname: Appelbaum – volume: 143 start-page: 2607 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0065 article-title: Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: A promising treatment publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-017-2513-4 contributor: fullname: Lin – volume: 2019 year: 2019 ident: 10.1016/j.tvir.2020.100675_bib0060 article-title: Immunomodulatory effect after irreversible electroporation in patients with locally advanced pancreatic cancer publication-title: J Oncol doi: 10.1155/2019/9346017 contributor: fullname: He – volume: 46 start-page: 341 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0036 article-title: The role of pancreatic enzyme replacement therapy in unresectable pancreatic cancer: A prospective cohort study publication-title: Pancreas doi: 10.1097/MPA.0000000000000767 contributor: fullname: Saito – volume: 41 start-page: 1257 year: 2018 ident: 10.1016/j.tvir.2020.100675_bib0045 article-title: Conductivity rise during irreversible electroporation: True permeabilization or heat? publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-018-1971-7 contributor: fullname: Ruarus – volume: 8 start-page: 101795 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0064 article-title: An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer publication-title: Oncotarget doi: 10.18632/oncotarget.21974 contributor: fullname: Lin – volume: 27 start-page: 2521 year: 2017 ident: 10.1016/j.tvir.2020.100675_bib0039 article-title: MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation publication-title: Eur Radiol doi: 10.1007/s00330-016-4581-2 contributor: fullname: Vroomen – volume: 23 start-page: 4352 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0058 article-title: Systematic review of resection rates and clinical outcomes after FOLFIRINOX-based treatment in patients with locally advanced pancreatic cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5373-2 contributor: fullname: Rombouts – volume: 11 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0011 article-title: Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: A systematic review of experimental studies publication-title: PloS One doi: 10.1371/journal.pone.0166987 contributor: fullname: Vogel – volume: 38 start-page: 760 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0030 article-title: Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: A case report publication-title: Cardiovasc Intervent Radiol doi: 10.1007/s00270-014-0950-x contributor: fullname: Scheffer – volume: 54 start-page: 1101 year: 2013 ident: 10.1016/j.tvir.2020.100675_bib0027 article-title: 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin alphavbeta6 publication-title: J Nucl Med doi: 10.2967/jnumed.112.110759 contributor: fullname: Hackel – volume: 18 start-page: 159 year: 2015 ident: 10.1016/j.tvir.2020.100675_bib0034 article-title: Irreversible electroporation for colorectal liver metastases publication-title: Tech Vasc Interv Radiol doi: 10.1053/j.tvir.2015.06.007 contributor: fullname: Scheffer – volume: 27 start-page: 895 year: 2010 ident: 10.1016/j.tvir.2020.100675_bib0037 article-title: CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency publication-title: Adv Ther doi: 10.1007/s12325-010-0085-7 contributor: fullname: Kuhn – volume: 23 start-page: 1736 year: 2016 ident: 10.1016/j.tvir.2020.100675_bib0068 article-title: Single-institution experience with irreversible electroporation for T4 pancreatic cancer: First 50 patients publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-5034-x contributor: fullname: Kluger – volume: 25 start-page: 1589 year: 2014 ident: 10.1016/j.tvir.2020.100675_bib0038 article-title: Irreversible electroporation ablation of malignant hepatic tumors: Subacute and follow-up CT appearance of ablation zones publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2014.06.026 contributor: fullname: Dollinger |
| SSID | ssj0025158 |
| Score | 2.4099572 |
| SecondaryResourceType | review_article |
| Snippet | Several minimally invasive image guided tumor ablation techniques have been added to the treatment spectrum for locally advanced pancreatic cancer (LAPC).... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | 100675 |
| SubjectTerms | ablation abscopal effect image-guided immunomodulation immunotherapy irreversible electroporation locally advanced pancreatic cancer |
| Title | Irreversible Electroporation for Locally Advanced Pancreatic Cancer |
| URI | https://dx.doi.org/10.1016/j.tvir.2020.100675 https://search.proquest.com/docview/2418132903 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA77cfEiiorzx4jgTeq2pknb4ygbm84x1MFuIW0SmIxuzE7w4t_uS5MKinjw1DYlpXx5vO898r0XhK6jULDMT6mnsx7zgkCmnmBaeN1Qx5RSqf3y_JSHKRvNg7sFXdRQUtXCGFml8_3Wp5fe2o10HJqdzXLZeep1oxjYmflgp8A0izpqAh2Zvdpmf3w_mn7lXUDZtiLOCHpggqudsTKv4m1p2oL6pV6AGbnh7_z0w1OX9DM8QPsubsR9-2uHqKbyI5SMt6YDE-T76UrhgT3RZuMWFUM4iieGqlbvuO-2-vEMLmWcmOHEjGyP0Xw4eE5GnjsVwctIGBaeMl3cdAD3CmInCfTNiMhYTKTPTFVrSGPIgqQmRGU0IkL7VGVShUwFsYI35AQ18nWuThGWQipfQ0gUxjoQUgstoyASJBQ9oYDbWuimwoJvbPMLXqnCXrhBjhvkuEWuhWgFF_-2hBy885_zripsOdi22bAQuVrvXjksZwTZctwlZ__89jnaM09W23WBGsV2py4hiijSNqrffvTaYCvJ42TWdjbzCZVax_E |
| link.rule.ids | 314,780,784,4502,24116,27924,27925,45585,45679 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA5zHvQiioq_reBN6rbmV3scZWPTbQhusFvImgQmoxuzE7z4t_vSpIIiHjy1JGkJXx7vfSHfe0HoNuaSZdGMhiZrsZAQNQslMzJscpNQSpWJyvtThiPWm5CHKZ3WUFrlwlhZpff9zqeX3tq3NDyajdV83nhuNeMEojOLwE4h0ky30DahwH7BqO8_vnQeMIK6fDgr54HhPnPGibyKt7ktChqVagFmxYa_R6cffroMPt19tOdZY9B2EztANZ0forS_tvWXYLc_W-ig4-6zWfklDYCMBgMbqBbvQdsf9AdP8ChZYhaktmV9hCbdzjjthf5OhDDDnBehtjXcDIF3DcxJQfBmWGYswSpiNqeV0wT2QMpgrDMaY2kiqjOlOdMk0dCDj1E9X-b6BAVKKh0ZIEQ8MUQqI42KSSwxly2pIbKdorsKC7FypS9EpQl7ERY5YZETDrlTRCu4xLcFFOCb__zupsJWgGXb4wqZ6-XmVQC3iGGvnDTx2T__fY12euPhQAz6o8dztGt7nMrrAtWL9UZfAp8oZlelvXwCIi_HNQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Irreversible+Electroporation+for+Locally+Advanced+Pancreatic+Cancer&rft.jtitle=Techniques+in+vascular+and+interventional+radiology&rft.au=Timmer%2C+Florentine+E.F.&rft.au=Geboers%2C+Bart&rft.au=Ruarus%2C+Alette+H.&rft.au=Schouten%2C+Evelien+A.C.&rft.date=2020-06-01&rft.pub=Elsevier+Inc&rft.issn=1089-2516&rft.eissn=1557-9808&rft.volume=23&rft.issue=2&rft_id=info:doi/10.1016%2Fj.tvir.2020.100675&rft.externalDocID=S108925162030024X |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1089-2516&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1089-2516&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1089-2516&client=summon |